BMP4 and BMP7 suppress StAR and progesterone production via ALK3 and SMAD1/5/8-SMAD4 in human granulosa-lutein cells

Endocrinology (United States)

Volumn 156, Issue 11, 2015, Pages 4269-4280

  Zhang, Han ^a   Klausen, Christian ^a   Zhu, Hua ^a   Chang, Hsun Ming ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; PROGESTERONE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 4; RECOMBINANT OSTEOGENIC PROTEIN 1; SMAD PROTEIN; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ACTIVIN RECEPTOR; BMP4 PROTEIN, HUMAN; BMP7 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 4; OSTEOGENIC PROTEIN 1; PHOSPHOPROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GRANULOSA CELL; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; LUTEAL CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ADULT; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; FEMALE; METABOLISM;

ACTIVIN RECEPTORS; ADULT; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; CELL LINE; FEMALE; HUMANS; LUTEAL CELLS; PHOSPHOPROTEINS; PROGESTERONE; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84946052727     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1494     Document Type: Article

References (56)

1. Gwynne JT, Strauss JF 3rd. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev. 1982;3:299-329.
2. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314-28322.
3. Simpson ER. Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis. Mol Cell Endocrinol. 1979;13: 213-227.
4. Lachance Y, Luu-The V, Labrie C, et al. Characterization of human 3/3-hydroxysteroid dehydrogenase/]delta] 5-5 4-isomerase gene and its expression in mammalian cells. J Biol Chem. 1990;265:20469-20475.
5. Hedin L, Rodgers RJ, Simpson ER, Richards JS. Changes in content of cytochrome P450(17)a, cytochrome P450scc, and 3-hydroxy-3-methylglutaryl CoA reductase in developing rat ovarian follicles and corpora lutea: correlation with theca cell steroidogenesis. Biol Re-prod. 1987;37:211-223.
6. Oonk RB, Krasnow JS, Beattie WG, Richards JS. Cyclic AMP-de-pendent and-independent regulation of cholesterol side chain cleavage cytochrome P-450 (P-450scc) in rat ovarian granulosa cells and corpora lutea. cDNA and deduced amino acid sequence of rat P-450scc. J Biol Chem. 1989;264:21934-21942.
7. Kaynard AH, Periman LM, Simard J, Melner MH. Ovarian 3/3-hydroxysteroid dehydrogenase and sulfated glycoprotein-2 gene expression are differentially regulated by the induction of ovulation, pseudopregnancy, and luteolysis in the immature rat. Endocrinology. 1992;130:2192-2200.
8. Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the corpus luteum. Endocrine. 2000;12:1-9.
9. Drummond AE. TGF/3 signalling in the development of ovarian function. Cell Tissue Res. 2005;322:107-115.
10. Mueller TD, Nickel J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 2012;586:1846-1859.
11. Erickson GF, Shimasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol. 2003;1:9.
12. Shimasaki S, Zachow RJ, Li D, et al. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA. 1999; 96:7282-7287.
13. Abir R, Ben-Haroush A, Melamed N, Felz C, Krissi H, Fisch B. Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults. Fertil Steril. 2008;89:1430-1440.
14. Pierre A, Pisselet C, Dupont J, et al. Molecular basis of bone morphogenetic protein-4 inhibitory action on progesterone secretion by ovine granulosa cells. J Mol Endocrinol. 2004;33:805-817.
15. Mulsant P, Lecerf F, Fabre S, et al. Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proc Natl Acad Sci USA. 2001;98:5104-5109.
16. Lee WS, Otsuka F, Moore RK, Shimasaki S. Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod. 2001;65:994-999.
17. Chang HM, Cheng JC, Taylor E, Leung PC. Oocyte-derivedBMP15 but not GDF9 down-regulates connexin43 expression and decreases gap junction intercellular communication activity in immortalized human granulosa cells. Mol Hum Reprod. 2014;20:373-383.
18. Chang HM, Klausen C, Leung PC. Antimullerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulo-sa-lutein cells. Fertil Steril. 2013;100:585-592. e581.
19. Lie BL, Leung E, Leung PC, Auersperg N. Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol. 1996;120: 169-176.
20. Fang L, Chang HM, Cheng JC, Leung PC, Sun YP. TGF-/31 down-regulates StAR expression and decreases progesterone production through Smad3 and ERK1/2 signaling pathways in human granulosa cells. J Clin Endocrinol Metab. 2014;99:E2234-E2243.
21. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-/3/BMP signaling. J Cell Physiol. 2001;187:265-276.
22. Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008;4:33-41.
23. Hao J, Ho JN, Lewis JA, et al. In vivo structure-Activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010;5:245-253.
24. Inman GJ, Nicolas FJ, Callahan JF, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65-74.
25. Oktem O, Urman B. Understanding follicle growth in vivo. Hum Reprod. 2010;25:2944-2954.
26. Feldberg D, Goldman GA, Ashkenazi J, Dicker D, Shelef M, Goldman JA. The impact of high progesterone levels in the follicular phase of in vitro fertilization (IVF) cycles: a comparative study. J In Vitro Fertil Embryo Transfer. 1989;6:11-14.
27. Ravindranath N, Little-Ihrig L, Benyo DF, Zeleznik AJ. Role of luteinizing hormone in the expression of cholesterol side-chain cleavage cytochrome P450 and 3/3-hydroxysteroid dehydrogenase, 55-4 isomerase messenger ribonucleic acids in the primate corpus luteum. Endocrinology. 1992;131:2065-2070.
28. Chaffin CL, Dissen GA, Stouffer RL. Hormonal regulation of steroidogenic enzyme expression in granulosa cells during the peri-ovulatory interval in monkeys. Mol Hum Reprod. 2000;6:11-18.
29. Devoto L, Kohen P, Gonzalez RR, et al. Expression of steroidogenic acute regulatory protein in the human corpus luteum throughout the luteal phase. J Clin Endocrinol Metab 2001;86:5633-5639.
30. Sekar N, Lavoie HA, Veldhuis JD. Concerted regulation of steroidogenic acute regulatory gene expression by luteinizing hormone and insulin (or insulin-like growth factor I) inprimary cultures of porcine granulosa-luteal cells. Endocrinology. 2000;141:3983-3992.
31. Knight PG, Glister C. TGF-/3 superfamily members and ovarian follicle development. Reproduction. 2006;132:191-206.
32. Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev. 2011;78:9-21.
33. Chang HM, Cheng JC, Klausen C, Leung PC. BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells. Mol Endocrinol. 2013;27:2093-2104.
34. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4,-6 and-7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction. 2004;127: 239-254.
35. Juengel JL, Reader KL, Bibby AH, et al. The role of bone morphogenetic proteins 2, 4, 6 and 7 during ovarian follicular development in sheep: contrast to rat. Reproduction. 2006;131:501-513.
36. Yamashita H, Murayama C, Takasugi R, Miyamoto A, Shimizu T. BMP-4 suppresses progesterone production by inhibiting histone H3 acetylation of StAR in bovine granulosa cells in vitro. Mol Cell Biochem. 2011;348:183-190.
37. Fabre S, Pierre A, Pisselet C, et al. The Booroola mutation in sheep is associated with an alteration of the bone morphogenetic protein receptor-IB functionality. J Endocrinol. 2003;177:435-444.
38. Miyoshi T, Otsuka F, Suzuki J, et al. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Biol Reprod. 2006;74:1073-1082.
39. Glister C, Richards SL, Knight PG. Bone morphogenetic proteins (BMP)-4,-6, and-7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology. 2005; 146:1883-1892.
40. Oktem O, Urman B. Patients with polycystic ovarian syndrome (PCOS) have decreased serum levels of theca cell derived bone morphogenetic protein-7 (BMP-7): a new hormonal marker? Presented as abstracts at: 67th Annual Meeting of the American Society for Reproductive Medicine (ASRM), 2011, Orlando, FL, p S40 (Abstract O-133).
41. van Houten EL, Laven JS, Louwers YV, McLuskey A, Themmen AP, Visser JA. Bone morphogenetic proteins and the polycystic ovary syndrome. J Ovarian Res. 2013;6:32.
42. Son JW, Kim MK, Park YM, et al. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals. Endocr J. 2011;58:39-46.
43. Scialla JJ, Kao WH, Crainiceanu C, et al. Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014;9:745-755.
44. Albilia JB, Tenenbaum HC, Clokie CM, et al. Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints. J Orthopaed Res. 2013;31:44-52.
45. Zeng J, Jiang Y, Xiang S, Chen B. Serum bone morphogenetic protein 7, insulin resistance, and insulin secretion in non-diabetic individuals. Diabet Res Clin Pract. 2011;93:e21-e24.
46. Khalaf M, Morera J, Bourret A, et al. BMP system expression in GCs from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis. Eur J Endocrinol. 2013;168:437-444.
47. Sugiyama R, Fuzitou A, Takahashi C, et al. Bone morphogenetic protein 2 may be a good predictor of success in oocyte fertilization during assisted reproductive technology. Hum Cell. 2010;23: 83-88.
48. Chang HM, Cheng JC, Fang L, et al. Recombinant BMP4 and BMP7 downregulate pentraxin 3 in human granulosa cells. J Clin Endocrinol Metab. 2015;100:E365-E374.
49. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005;19:2783-2810.
50. Massague J. TGF/3 signalling in context. Nat Rev Mol Cell Biol. 2012;13:616-630.
51. Manna PR, Dyson MT, Stocco DM. Role of basic leucine zipper proteins in transcriptional regulation of the steroidogenic acute regulatory protein gene. Mol Cell Endocrinol. 2009;302:1-11.
52. Shi J, Yoshino O, Osuga Y, et al. Bone morphogenetic protein-2 (BMP-2) increases gene expression of FSH receptor and aromatase and decreases gene expression of LH receptor and StAR in human granulosa cells. Am J Reprod Immunol. 2011;65:421-427.
53. Chang HM, Cheng JC, Klausen C, Taylor EL, Leung PC. Effects of recombinant activins on steroidogenesis in human granulosa-lutein cells. J Clin Endocrinol Metab. 2014;99:E1922-E1932.
54. ten Dijke P, Yamashita H, Sampath TK, et al. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic pro-tein-4. J Biol Chem. 1994;269:16985-16988.
55. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem. 2008;283:20948-20958.
56. Edson MA, Nalam RL, Clementi C, et al. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol. 2010;24:1251-1266.